PCN129 Emerging Market Access Trends: Pricing and Coverage of Targeted Cancer Therapies in Russia (2011-2012)

Value in Health - United Kingdom
doi 10.1016/j.jval.2012.08.2169
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Ovarian Cancer: Emerging Molecular-Targeted Therapies

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2012English

Superbugs: Current Trends and Emerging Therapies

2012English

Targeted Treatment of Recurrent Platinum-Resistant Ovarian Cancer: Current and Emerging Therapies

Cancer Management and Research
Oncology
2010English

Targeted Cancer Therapies

Chinese Journal of Cancer
2011English

Asset Pricing in a Segmented Emerging Market

Journal of Applied Economics
EconomicsEconometricsFinance
2000English

Metastatic Triple Negative Breast Cancer: Optimizing Treatment Options, New and Emerging Targeted Therapies

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2017English

Prm70 - Non-Small Cell Lung Cancer Market Analysis for Targeted Therapies in Turkey

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Targeted Therapies in Cholangiocarcinoma: Emerging Evidence From Clinical Trials

Medicina
Medicine
2019English

Targeted Therapies in Cancer and Mechanisms of Resistance

Journal of Molecular Medicine
Molecular MedicineDrug DiscoveryGenetics
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy